MarketScreener Editorial Features Cytokinetics, Inc. Nasdaq
Equities
US23282W1009
End-of-day quote
Other stock markets
|
||
- USD | - |
|
06-24 | JPMorgan Cuts Price Target on Cytokinetics to $65 From $77, Maintains Overweight Rating | MT |
06-17 | Cytokinetics Insider Sold Shares Worth $262,750, According to a Recent SEC Filing | MT |
MarketScreener Editorial Features
![]() | Stocks in motion: e.l.f Beauty soars along with Nvidia | May 23, 2024 at 04:36 pm |
Today on Wall Street: Breaking record after record | August 13, 2021 at 02:05 pm |
- Stock Market
- Equities
- CYTK Stock
- Stock
- News Cytokinetics, Inc.
- MarketScreener Editorial Features